Latest news with #Healthpeak
Yahoo
07-07-2025
- Business
- Yahoo
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Third Quarter of 2025
DENVER, July 07, 2025--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that on July 7, 2025, its Board of Directors declared a monthly common stock cash dividend of $0.10167 per share for the third quarter of 2025, payable on the payment dates set forth in the table below to stockholders of record as of the close of business on the corresponding record date in the table below. The monthly dividend reflects a quarterly dividend amount of $0.305 per share of common stock, and an annualized dividend amount of $1.22 per share of common stock. Record Date Payment Date Amount July 18, 2025 July 31, 2025 $0.10167 per common share August 18, 2025 August 29, 2025 $0.10167 per common share September 19, 2025 September 30, 2025 $0.10167 per common share ABOUT HEALTHPEAK PROPERTIES Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. For more information regarding Healthpeak, visit View source version on Contacts Andrew Johns, CFASenior Vice President – Finance and Investor Relations720-428-5050 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
26-06-2025
- Business
- Business Wire
Healthpeak Properties Announces Second Quarter 2025 Earnings Release Date and Conference Call Details
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report second quarter 2025 financial results after the close of trading on the New York Stock Exchange on Thursday, July 24, 2025. Healthpeak will host a conference call and webcast on Friday, July 25, 2025, at 8:00 a.m. Mountain Time (10:00 a.m. Eastern Time) to review its financial performance and operating results. The conference call can be accessed in the following ways: Healthpeak's website: Webcast: Joining via webcast is recommended for those who will not be asking questions. Telephone: The participant dial-in number is (800) 715-9871. An archive of the webcast will be available on Healthpeak's website through July 24, 2026, and a telephonic replay can be accessed through August 1, 2025, by dialing (800) 770-2030 and entering conference ID number 95156. ABOUT HEALTHPEAK PROPERTIES Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery. For more information regarding Healthpeak, visit
Yahoo
18-06-2025
- Business
- Yahoo
QurAlis Announces New Global Headquarters
30,000 square foot state-of-the-art office suite, lab, and research facility doubles QurAlis' footprint in Cambridge's vibrant Alewife Biotech Park CAMBRIDGE, Mass., June 18, 2025--(BUSINESS WIRE)--QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of neurodegenerative and neurological diseases, today announced the opening of its new global corporate headquarters in Cambridge, MA. The company's new 30,000 square foot state-of-the-art research facility and office space located at 35 Cambridgepark Drive ("35 CPD"), doubles QurAlis' footprint in the heart of Cambridge's vibrant Alewife Biotech Park. "Maintaining our corporate headquarters in Cambridge positions us at the heart of a thriving biotechnology hub with world-class talent and leading research institutions," said Jason Brown, MBA, chief financial officer at QurAlis. "The facility at Alewife allowed us to expand our R&D footprint, lab capacity, and office space to support QurAlis' growth and enhance our leading precision medicine portfolio and platform capabilities. Our new headquarters provides our employees with a high-tech work environment conducive to collaboration and innovation with improved space and amenities. The space will continue to foster our mission-driven culture committed to discovering and developing medicines that have the potential to transform the lives of people living with neurodegenerative and neurological diseases." QurAlis and its landlord, Healthpeak, fully built out and furnished QurAlis' lab and office suite prior to occupancy. QurAlis' new headquarters offers a larger space with enhanced lab and discovery resources and a 5,000 square foot conferencing space for meeting and collaboration. More than one-third of the new facility is dedicated to a state-of-the-art 11,000 square foot lab with an expansive tissue culture suite and addition of an onsite antisense oligonucleotide (ASO) chemistry manufacturing lab to support programs utilizing QurAlis' FlexASO® technology platform. FlexASO® was developed to generate splice-switching ASOs with improved potency, increased therapeutic index and improved bio-distribution. This bespoke platform has the potential to tackle the spectrum of neurodegenerative and neurological diseases. "Healthpeak welcomes QurAlis to 35 Cambridgepark Drive," said Scott Bohn, chief development officer and head of lab at Healthpeak. "QurAlis' need for Class A lab space to progress their groundbreaking neuroscience work aligned seamlessly with our purpose-built life science campus, offering state-of-the-art amenities, a sustainable LEED Gold design, and unbeatable proximity to Alewife Station – an ideal environment for QurAlis' continued innovation and growth." Part of a 450,000 square foot RSF, three-building campus, 35 CPD is a LEED Gold 224,000 square foot RSF purpose-built life science building strategically located in West Cambridge directly across from the Alewife MBTA Station (Red line), at the end of Massachusetts Route 2, on Minuteman bike path and walkable to the Fresh Pond Reservation. 35 CPD, with attached garage, provides ample tenant amenities in the building including a Craft Food Hall, exclusive fitness center, private shower and locker rooms, secure bike room, client lounge, and activated outdoor spaces. QurAlis was represented in their search and lease negotiations by Carolyn Wheatley and Marc Consalvi at JLL. About QurAlis Corporation At QurAlis, we are neuro pioneers on a quest to cure, boldly seeking to translate scientific breakthroughs into powerful precision medicines. We work collaboratively with a relentless pursuit of knowledge, precise attention to craft, and compassion to discover and develop medicines that have the potential to transform the lives of people living with neurodegenerative and neurological diseases. QurAlis is the leader in development of precision therapies for amyotrophic lateral sclerosis (ALS). In addition to ALS, QurAlis is advancing a robust precision medicine pipeline to bring effective disease-modifying therapeutics to patients suffering from severe diseases defined by genetics and clinical biomarkers. For more information, please visit or follow us on X @QurAlisCo or LinkedIn. View source version on Contacts Kathy 310-403-8951
Business Wire
18-06-2025
- Business
- Business Wire
QurAlis Announces New Global Headquarters
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- QurAlis Corporation ('QurAlis'), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of neurodegenerative and neurological diseases, today announced the opening of its new global corporate headquarters in Cambridge, MA. The company's new 30,000 square foot state-of-the-art research facility and office space located at 35 Cambridgepark Drive ('35 CPD'), doubles QurAlis' footprint in the heart of Cambridge's vibrant Alewife Biotech Park. 'Maintaining our corporate headquarters in Cambridge positions us at the heart of a thriving biotechnology hub with world-class talent and leading research institutions,' said Jason Brown, MBA, chief financial officer at QurAlis. 'The facility at Alewife allowed us to expand our R&D footprint, lab capacity, and office space to support QurAlis' growth and enhance our leading precision medicine portfolio and platform capabilities. Our new headquarters provides our employees with a high-tech work environment conducive to collaboration and innovation with improved space and amenities. The space will continue to foster our mission-driven culture committed to discovering and developing medicines that have the potential to transform the lives of people living with neurodegenerative and neurological diseases.' QurAlis and its landlord, Healthpeak, fully built out and furnished QurAlis' lab and office suite prior to occupancy. QurAlis' new headquarters offers a larger space with enhanced lab and discovery resources and a 5,000 square foot conferencing space for meeting and collaboration. More than one-third of the new facility is dedicated to a state-of-the-art 11,000 square foot lab with an expansive tissue culture suite and addition of an onsite antisense oligonucleotide (ASO) chemistry manufacturing lab to support programs utilizing QurAlis' FlexASO® technology platform. FlexASO® was developed to generate splice-switching ASOs with improved potency, increased therapeutic index and improved bio-distribution. This bespoke platform has the potential to tackle the spectrum of neurodegenerative and neurological diseases. 'Healthpeak welcomes QurAlis to 35 Cambridgepark Drive,' said Scott Bohn, chief development officer and head of lab at Healthpeak. 'QurAlis' need for Class A lab space to progress their groundbreaking neuroscience work aligned seamlessly with our purpose-built life science campus, offering state-of-the-art amenities, a sustainable LEED Gold design, and unbeatable proximity to Alewife Station – an ideal environment for QurAlis' continued innovation and growth.' Part of a 450,000 square foot RSF, three-building campus, 35 CPD is a LEED Gold 224,000 square foot RSF purpose-built life science building strategically located in West Cambridge directly across from the Alewife MBTA Station (Red line), at the end of Massachusetts Route 2, on Minuteman bike path and walkable to the Fresh Pond Reservation. 35 CPD, with attached garage, provides ample tenant amenities in the building including a Craft Food Hall, exclusive fitness center, private shower and locker rooms, secure bike room, client lounge, and activated outdoor spaces. QurAlis was represented in their search and lease negotiations by Carolyn Wheatley and Marc Consalvi at JLL. About QurAlis Corporation At QurAlis, we are neuro pioneers on a quest to cure, boldly seeking to translate scientific breakthroughs into powerful precision medicines. We work collaboratively with a relentless pursuit of knowledge, precise attention to craft, and compassion to discover and develop medicines that have the potential to transform the lives of people living with neurodegenerative and neurological diseases. QurAlis is the leader in development of precision therapies for amyotrophic lateral sclerosis (ALS). In addition to ALS, QurAlis is advancing a robust precision medicine pipeline to bring effective disease-modifying therapeutics to patients suffering from severe diseases defined by genetics and clinical biomarkers. For more information, please visit or follow us on X @QurAlisCo or LinkedIn.
Yahoo
14-05-2025
- Business
- Yahoo
Got $1,000 to Invest? This Healthy Monthly Dividend Stock Could Turn It Into Over $70 of Annual Passive Income.
Healthpeak Properties pays a monthly dividend yielding 7%. The healthcare REIT's portfolio produces stable and growing income. It has a very healthy financial profile. 10 stocks we like better than Healthpeak Properties › Investing money in dividend-paying stocks is an easy way to start generating passive income. Many companies pay dividends, which gives you lots of options. One ideal option for those seeking to collect recurring passive income is Healthpeak Properties (NYSE: DOC). The real estate investment trust (REIT) recently switched to paying monthly dividends instead of the typical quarterly schedule, which better aligns the payment with your monthly expenses. It also offers a very attractive dividend yield currently above 7% (significantly higher than the S&P 500's sub-1.5% yield). A $1,000 investment would produce more than $70 of annual passive income at that rate. Here's a closer look at this top-notch income stock. Healthpeak Properties owns a diversified portfolio of healthcare real estate. It invests in state-of-the-art lab campuses, outpatient medical buildings, and continuing care retirement communities. It focuses on owning high-quality buildings in prime locations because they benefit from growing demand. The healthcare REIT's outpatient medical building portfolio provides it with stable and growing rental income. It signs five-to-seven-year leases that feature low-single-digit annual rent bumps with high-quality healthcare systems that need space near hospitals. Meanwhile, its purpose-built lab portfolio is in high demand by biopharma companies, which drives healthy rent growth as legacy leases expire. Finally, its high-quality senior housing properties appeal to active seniors, which drives longer stays and higher occupancy. Healthpeak's portfolio works together to deliver stable and growing rental income to support the REIT's monthly dividend. It generated $1.60 per share of adjusted funds from operations (FFO) in 2024. That can easily cover its annual dividend outlay of $1.22 per share. Healthpeak has been growing its adjusted FFO briskly in recent years (19% over the past three years). Several factors are driving this growth. A big growth catalyst was its 2023 merger with Physicians Realty Trust. The deal created a premier owner, operator, and developer of healthcare real estate. It has been steadily capturing synergies from that transaction ($50 million last year and another $15 million expected in 2025), which have helped boost its bottom line. Healthpeak has also benefited from rent growth across its portfolio. Last year was a record year of leasing across its outpatient medical and lab portfolio. It signed new leases at much higher rates than expiring contracts (7% on average for outpatient and 11% for lab). It was also a record year of performance by its senior housing portfolio (21% same-store net operating income growth). On top of that, the REIT is investing capital to grow its portfolio. It has spent money on several marquee lab development and redevelopment projects that have the potential to add more than $60 million to its bottom line in 2025 and beyond. It has also agreed to invest $161 million across several properties, including a preferred equity investment in a lab development project, a loan to develop a medical office building in Texas, and a loan to redevelop a lab building in California. Healthpeak also entered into a partnership with a company to develop residential housing as part of a mixed-use lab and residential area in Massachusetts. Healthpeak has ample financial flexibility to continue making new investments. The company currently has about $500 million to $1 billion in capacity to make accretive new investments or repurchase its shares. These growth drivers should enable the REIT to increase its high-yielding dividend. It recently bumped its payout up by 1.7%. Healthpeak Properties' high-quality portfolio of healthcare properties produces stable and growing rental income. That supports the REIT's high-yielding monthly dividend. With built-in growth and ample investment capacity, Healthpeak should be able to increase its high-yielding payout in the future. That makes it a great option for those seeking to generate a healthy stream of passive income. Before you buy stock in Healthpeak Properties, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Healthpeak Properties wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $598,613!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $753,878!* Now, it's worth noting Stock Advisor's total average return is 922% — a market-crushing outperformance compared to 169% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 12, 2025 Matt DiLallo has no position in any of the stocks mentioned. The Motley Fool recommends Healthpeak Properties. The Motley Fool has a disclosure policy. Got $1,000 to Invest? This Healthy Monthly Dividend Stock Could Turn It Into Over $70 of Annual Passive Income. was originally published by The Motley Fool Sign in to access your portfolio
